Recall Record

Cambridge, N/A, United Kingdom

Cytocell Ltd. recalls

13 recalls recorded since 2018, most recently on 24 May 2023. 2 are listed as ongoing. Status and classification are as published by the FDA.

Recalls13
Ongoing (FDA)2
Terminated or completed11
Class I (FDA)0

Ongoing Class II Medical devices

Recall started
24 May 2023
Reason
DNAs used during the manufacture of two affected models were accidentally inverted during manufacturing.
Distribution
US Nationwide distribution in the states of CA, FL, OH, & SC.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2210-2023, Z-2209-2023

Terminated Class II Medical devices

Recall started
27 October 2022
Terminated
27 December 2024
Reason
An error with the chromomap on version 1 of the package insert which is incorrect. The nucleotide locations specified in the insert are correct but the map has been created using the wrong coordinates.
Distribution
TX
Initiated
Voluntary: Firm initiated
Recall number
Z-0341-2023

Terminated Class II Medical devices

Recall started
27 October 2022
Terminated
27 December 2024
Reason
Device is mislabeled. The package insert for this ASR device contains a chromomap - an image showing the position the FISH probe maps to on the specific chromosome. For this device the chromomap in version 1 of the package insert is incorrect and doesn't not match the probe design or specification contained on the package insert
Distribution
TX
Initiated
Voluntary: Firm initiated
Recall number
Z-0353-2023

Terminated Class III Medical devices

Recall started
14 February 2022
Terminated
12 June 2023
Reason
Labelled with an incorrect expiry date on the outer label with an extended expiry date than the validated shelf life. The correct expiry date for the device is 2022-02 and not 2023-05 as shown on the outer label.
Distribution
US Nationwide distribution in the states of CT, TX.
Initiated
Voluntary: Firm initiated
Recall number
Z-0824-2022

Terminated Class III Medical devices

Recall started
4 February 2022
Terminated
6 November 2024
Reason
May show unexpected locus specific signals in addition to those at 14q32.
Distribution
MN
Initiated
Voluntary: Firm initiated
Recall number
Z-0814-2022

Terminated Class II Medical devices

Recall started
18 January 2022
Terminated
8 November 2024
Reason
individual components have been labelled with incorrect colours. The red and green colours are opposite to those specified in the product labelling. The EGR1 probe is labelled in green rather than red and the control probe labelled in red rather than green. The expected positive signal pattern in the case of 1x deleted 5q will be 1G2R instead of 1R2G, an incorrect result
Distribution
US Nationwide distribution in the states of Hawaii, Missouri, Pennsylvania, Tennessee.
Initiated
Voluntary: Firm initiated
Recall number
Z-0741-2022

Terminated Class II Medical devices

Recall started
27 May 2021
Terminated
9 May 2022
Reason
May show unexpected locus specific signals in addition to those at 19p13.3. Users may observe faint additional locus specific signals at 9q34
Distribution
US Nationwide distribution in the states of CA, IL, KY, NY, OH, TX, UT, VA.
Initiated
Voluntary: Firm initiated
Recall number
Z-2323-2021

Terminated Class II Medical devices

Recall started
17 May 2021
Terminated
15 August 2022
Reason
The device may show unexpected locus specific signals in addition to those at 22q. Users may observe faint additional locus specific signals at 20p12/13.
Distribution
Distribution to US states of CA, IL, MO, NY, PA, TX, and UT, and Canada.
Initiated
Voluntary: Firm initiated
Recall number
Z-2134-2021

Ongoing Class II Medical devices

Recall started
19 March 2021
Reason
Users may observe additional locus specific signals at 9q34. The device pack insert indicates the probe has no known cross-reactivity to 9q34.
Distribution
US Nationwide distribution in the states of TX, OH, NY, IL, CT, AL, IA, MO.
Initiated
Voluntary: Firm initiated
Recall number
Z-1493-2021

Terminated Class II Medical devices

Recall started
22 December 2020
Terminated
7 June 2022
Reason
Users may observe very faint additional locus specific signals at 11q13. There is a low risk of a normal sample being reported as not normal in a resulting laboratory developed test (LDT) that utilizes the LPH511-A CRLF2 Distal Probe Green.
Distribution
Domestic distribution to California, Illinois, Michigan, Minnesota, New Jersey, Texas, and Washington. Foreign distribution to Canada.
Initiated
Voluntary: Firm initiated
Recall number
Z-1099-2021

Terminated Class II Medical devices

Recall started
17 July 2020
Terminated
30 September 2020
Reason
A low risk of a false positive result being issued with a laboratory developed test (LDT) that utilizes the LPH533-A NUP98 Distal Probe Green.
Distribution
Worldwide distribution - US Nationwide distribution and the country of Canada.
Initiated
Voluntary: Firm initiated
Recall number
Z-2829-2020

Terminated Class III Medical devices

Recall started
26 April 2019
Terminated
16 July 2020
Reason
There is an error in the chromomap on the package insert.
Distribution
Worldwide Distribution - US Nationwide AL, CO, FL, HI, IA, IL, IN, KY, MA, MD, MI, MO, MS, NC, NJ, NY, TN, TX, UT, WA, and WI. The products were distributed to the following foreign countries: Canada.
Initiated
Voluntary: Firm initiated
Recall number
Z-1843-2019

Terminated Class III Medical devices

Recall started
15 March 2019
Terminated
13 October 2020
Reason
There is an error in the chromomap included in the labeling for the product.
Distribution
The products were distributed to the following US states: IL, TN.
Initiated
Voluntary: Firm initiated
Recall number
Z-1202-2019

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.